| Tumor necrosis factor inhibitors: clinical utility in autoimmune diseases MAV Willrich, DL Murray, MR Snyder Translational Research 165 (2), 270-282, 2015 | 182 | 2015 |
| Acute effect of Bauhinia forficata on serum glucose levels in normal and alloxan-induced diabetic rats FRMB Silva, B Szpoganicz, MG Pizzolatti, MAV Willrich, E de Sousa Journal of Ethnopharmacology 83 (1-2), 33-37, 2002 | 159 | 2002 |
| Comprehensive assessment of M-proteins using nanobody enrichment coupled to MALDI-TOF mass spectrometry JR Mills, MC Kohlhagen, S Dasari, PM Vanderboom, RA Kyle, ... Clinical chemistry 62 (10), 1334-1344, 2016 | 139 | 2016 |
| Laboratory testing requirements for diagnosis and follow-up of multiple myeloma and related plasma cell dyscrasias MAV Willrich, JA Katzmann Clinical Chemistry and Laboratory Medicine (CCLM) 54 (6), 907-919, 2016 | 125 | 2016 |
| Monitoring IgA multiple myeloma: immunoglobulin heavy/light chain assays JA Katzmann, MAV Willrich, MC Kohlhagen, RA Kyle, DL Murray, ... Clinical chemistry 61 (2), 360-367, 2015 | 84 | 2015 |
| Pharmacogenetics of OATP Transporters Reveals That SLCO1B1 c.388A>G Variant Is Determinant of Increased Atorvastatin Response AC Rodrigues, PMS Perin, SG Purim, VN Silbiger, FDV Genvigir, ... International journal of molecular sciences 12 (9), 5815-5827, 2011 | 76 | 2011 |
| Thrombotic microangiopathy care pathway: a consensus statement for the Mayo clinic complement alternative Pathway-Thrombotic microangiopathy (CAP-TMA) Disease-Oriented group RS Go, JL Winters, N Leung, DL Murray, MA Willrich, RS Abraham, ... Mayo Clinic Proceedings 91 (9), 1189-1211, 2016 | 73 | 2016 |
| CYP3A5⁎ 3A allele is associated with reduced lowering-lipid response to atorvastatin in individuals with hypercholesterolemia MAV Willrich, MH Hirata, FDV Genvigir, SS Arazi, IMM Rebecchi, ... Clinica chimica acta 398 (1-2), 15-20, 2008 | 71 | 2008 |
| Laboratory testing for monoclonal gammopathies: focus on monoclonal gammopathy of undetermined significance and smoldering multiple myeloma MAV Willrich, DL Murray, RA Kyle Clinical Biochemistry 51, 38-47, 2018 | 70 | 2018 |
| Mass spectrometry approaches for identification and quantitation of therapeutic monoclonal antibodies in the clinical laboratory PM Ladwig, DR Barnidge, MAV Willrich Clinical and Vaccine Immunology 24 (5), e00545-16, 2017 | 69 | 2017 |
| Atypical hemolytic uremic syndrome: Review of clinical presentation, diagnosis and management M Sridharan, RS Go, MAV Willrich Journal of immunological methods 461, 15-22, 2018 | 65 | 2018 |
| Quantitation of infliximab using clonotypic peptides and selective reaction monitoring by LC–MS/MS MAV Willrich, DL Murray, DR Barnidge, PM Ladwig, MR Snyder International immunopharmacology 28 (1), 513-520, 2015 | 60 | 2015 |
| Statin regulation of CYP3A4 and CYP3A5 expression MAV Willrich, MH Hirata, RDC Hirata Pharmacogenomics 10 (6), 1017-1024, 2009 | 56 | 2009 |
| CSF free light chain identification of demyelinating disease: comparison with oligoclonal banding and other CSF indexes KM Gurtner, E Shosha, SC Bryant, BD Andreguetto, DL Murray, SJ Pittock, ... Clinical Chemistry and Laboratory Medicine (CCLM) 56 (7), 1071-1080, 2018 | 53 | 2018 |
| The complement alternative pathway and preeclampsia L Alrahmani, MAV Willrich Current hypertension reports 20, 1-8, 2018 | 52 | 2018 |
| ABCB1 and ABCC1 expression in peripheral mononuclear cells is influenced by gene polymorphisms and atorvastatin treatment IMM Rebecchi, AC Rodrigues, SS Arazi, FDV Genvigir, MAV Willrich, ... Biochemical pharmacology 77 (1), 66-75, 2009 | 51 | 2009 |
| An international multi-center serum protein electrophoresis accuracy and M-protein isotyping study. Part I: factors impacting limit of quantitation of serum protein electrophoresis KA Turner, JL Frinack, MW Ettore, JR Tate, MS Graziani, JFM Jacobs, ... Clinical Chemistry and Laboratory Medicine (CCLM) 58 (4), 533-546, 2020 | 50 | 2020 |
| A universal solution for eliminating false positives in myeloma due to therapeutic monoclonal antibody interference JR Mills, MC Kohlhagen, MAV Willrich, T Kourelis, A Dispenzieri, ... Blood, The Journal of the American Society of Hematology 132 (6), 670-672, 2018 | 49 | 2018 |
| Screening method for M-proteins in serum using nanobody enrichment coupled to MALDI-TOF mass spectrometry MC Kohlhagen, DR Barnidge, JR Mills, J Stoner, KM Gurtner, AM Liptac, ... Clinical chemistry 62 (10), 1345-1352, 2016 | 49 | 2016 |
| Monoclonal antibody therapeutics as potential interferences on protein electrophoresis and immunofixation MAV Willrich, PM Ladwig, BD Andreguetto, DR Barnidge, DL Murray, ... Clinical Chemistry and Laboratory Medicine (CCLM) 54 (6), 1085-1093, 2016 | 48 | 2016 |
Fabiana Dalla Vecchia GenvigirAluno de Pós-Graduação da Universidade de São PauloVerified email at usp.br
